Cancer cell-specific PD-L1 expression is a predictor of poor outcome in patients with locally advanced oral cavity squamous cell carcinoma.
Journal: Journal for immunotherapy of cancer
Year: August 27, 2024
Oncologist
5
No OPD information available
Hemophagocytic Lymphohistiocytosis
Non-Langerhans-Cell Histiocytosis
Arachnoiditis
Histiocytosis
Reticulohistiocytoma
X-Linked Lymphoproliferative Disease
Kevin T. Thia is a male healthcare provider who specializes in treating various conditions such as Hemophagocytic Lymphohistiocytosis, Non-Langerhans-Cell Histiocytosis, Arachnoiditis, Histiocytosis, Reticulohistiocytoma, and X-Linked Lymphoproliferative Disease.
Kevin T. Thia helps patients by using special skills and treatments to address their medical needs. He is known for his expertise in diagnosing and managing complex diseases, providing personalized care to each patient.
Patients trust Kevin T. Thia because he communicates effectively, listens to their concerns, and involves them in decision-making about their health. He creates a supportive and compassionate environment that puts patients at ease during their treatment.
Kevin T. Thia stays updated with the latest medical knowledge and research through continuous education, attending conferences, and collaborating with other healthcare professionals. This ensures that he provides the most advanced and effective treatments to his patients.
In his interactions with colleagues, Kevin T. Thia is known for his collaborative approach and willingness to work as a team to deliver the best possible care to patients. He values teamwork and mutual respect among medical professionals.
Kevin T. Thia's work has had a positive impact on many patients' lives by improving their health outcomes and quality of life. His dedication to providing high-quality care and his commitment to staying informed about advancements in medicine have benefited numerous individuals under his care.
One of Kevin T. Thia's notable publications is "Cancer cell-specific PD-L1 expression is a predictor of poor outcome in patients with locally advanced oral cavity squamous cell carcinoma," published in the Journal for Immunotherapy of Cancer on August 27, 2024. This publication demonstrates his contribution to advancing medical knowledge and improving patient outcomes in the field of oncology.
Journal: Journal for immunotherapy of cancer
Year: August 27, 2024
Kevin T. Thia is an exceptional Oncologist who truly cares about his patients. He took the time to explain everything clearly and made me feel comfortable throughout my treatment. Highly recommend!
Dr. Thia is a compassionate and knowledgeable Oncologist. He provided me with excellent care and support during a difficult time. I am grateful for his expertise.
I had a great experience with Kevin T. Thia as my Oncologist. He is not only skilled in his field but also very kind and understanding. I felt well taken care of under his guidance.
Dr. Thia is a top-notch Oncologist who goes above and beyond for his patients. I felt confident in his treatment plan and appreciated his attention to detail. Thank you for everything!
Kevin T. Thia is an outstanding Oncologist who is dedicated to providing the best care possible. I felt supported and reassured throughout my treatment journey with him.
Dr. Thia is a wonderful Oncologist who is not only highly skilled but also very approachable. He listened to my concerns and tailored a treatment plan that worked best for me. Highly recommended!
I am extremely satisfied with the care I received from Kevin T. Thia as my Oncologist. He is a true professional who genuinely cares about his patients' well-being. Thank you for your exceptional service!